We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Sets Endpoints for BPH Device Trials
Guidance Sets Endpoints for BPH Device Trials
September 1, 2010
Sponsors conducting clinical trials of devices intended to treat benign prostatic hyperplasia (BPH) should conduct biocompatibility testing on the final, sterilized form of components that come in contact with patients.